(Q41428291)

30 September 2017

1 reference

title

New drug therapy for acute seizure management (English)

1 reference

30 September 2017

1 reference

Morton LD

1

1 reference

30 September 2017

Rizkallah E

series ordinal

2

1 reference

30 September 2017

Pellock JM

series ordinal

3

1 reference

30 September 2017

publication date

1 March 1997

1 reference

Seminars in pediatric neurology

30 September 2017

published in

1 reference

30 September 2017

volume

4

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

51-63

1 reference

A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Phenytoin prodrugs III: water-soluble prodrugs for oral and/or parenteral use

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Intramuscular administration of diphenylhydantoin. Histologic follow-up studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Pharmacology of ACC-9653 (phenytoin prodrug).

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Efficacy and adverse effects of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

The rate of decline of diphenylhydantoin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Antiepileptic drug mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Phenytoin dephosphorylates the alpha(-) catalytic subunit of (Na+, K+)-ATPase. A study in mouse, cat and human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Phenytoin hypersensitivity: 38 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

DIPHENYLHYDANTOIN ACTIVATED SEIZURES

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Cerebellar atrophy in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Esters of Hydantoic Acids as Prodrugs of Hydantoins

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Bioavailability of ACC-9653 (phenytoin prodrug)

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Performance of human mass balance/metabolite identification studies using stable isotope (13C, 15N) labeling and continuous-flow isotope-ratio mass spectrometry as an alternative to radioactive labeling methods

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Pharmacokinetics and safety of a phenytoin prodrug given i.v. or i.m. in patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Venous irritation related to intravenous administration of phenytoin versus fosphenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Fosphenytoin use in children

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Safety of intravenous valproate.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Pharmacokinetics and bioavailability of sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Pharmacokinetics of valproic acid in young and elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Disposition of sodium valproate in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Valproic acid pharmacokinetics in children. II. Discontinuation of concomitant antiepileptic drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Intravenous valproate: effects on plasma and saliva phenytoin levels

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Effect of infusion duration on valproate pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

The effect of sodium valproate on serum cortisol levels in healthy subjects and depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Biopharmaceutics of rectal administration of drugs in man IX. Comparative biopharmaceutics of diazepam after single rectal, oral, intramuscular and intravenous administration in man

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Prophylactic treatment with valproic acid or diazepam in children with febrile convulsions.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Home use of rectal diazepam to prevent status epilepticus in children with convulsive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Effect of prehospital treatment on the outcome of status epilepticus in children

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Home use of rectal diazepam for cluster and prolonged seizures: efficacy, adverse reactions, quality of life, and cost analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

Plasma concentrations of diazepam and N-desmethyldiazepam in newborn infants after intravenous, intramuscular, rectal and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

The administration of rectal diazepam for acute management of seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980009-5

7 January 2021

10.1016/S1071-9091(97)80009-5

Identifiers

DOI

1 reference

release_itvvzqvkhffp7ji5v7vicycy2y

30 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/itvvzqvkhffp7ji5v7vicycy2y

24 November 2022

mapped directly with Wikidata item

1 reference